SCHEMBL5344323

SCHEMBL5344323

Clc1ccc(-c2nc3ncc(-c4cccnc4)cn3c2-c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP1A2 P05177 2/20 0.44
LMNA P02545 1/20 0.44
CYP2C9 P11712 1/20 0.44
PKM P14618 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ROS1 P08922 1/20 0.43
SLC2A1 P11166 1/20 0.41
DPP4 P27487 7/20 0.40
DPP8 Q6V1X1 5/20 0.40
DPP9 Q86TI2 5/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5322366 0.88 AKT1 (0.50) CYP3A4CYP2C19SLC2A1AKT1AKT2
SCHEMBL5336486 0.84 AKT1 (0.39) CYP3A4CYP2C19CYP1A2DPP4DPP8
SCHEMBL5320273 0.82 DPP4 (0.52) CYP3A4CYP2C19CYP1A2SLC2A1DPP4
SCHEMBL5348641 0.81 DPP4 (0.39) CYP3A4CYP2C19CYP1A2DPP4DPP8
SCHEMBL5352678 0.81 AKT1 (0.43) CYP3A4CYP2C19CYP1A2LMNADPP4
SCHEMBL5336981 0.80 MAPT (0.41) CYP2C19CYP1A2LMNACYP2C9NPSR1
SCHEMBL5347503 0.80 NR4A2 (0.46) CYP3A4CYP2C19CYP1A2ROS1DPP4
SCHEMBL5335624 0.78 KDM4E (0.38) DPP4DPP8DPP9AKT1AKT2
SCHEMBL5341559 0.78 DPP4 (0.45) CYP3A4CYP2C19CYP1A2LMNACYP2C9
SCHEMBL5320900 0.78 DPP4 (0.52) CYP3A4CYP2C19CYP1A2SLC2A1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO claimed
WO-2007096764-A2 BICYCLIC HETEROARYL DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS GLENMARK PHARMACEUTICALS S.A. (US) 2007-08-30 WO disclosed